cifenline has been researched along with Chronic Disease in 5 studies
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study was designed to compare the efficacy and safety of cibenzoline and quinidine in ambulatory patients with ventricular arrhythmias." | 9.06 | Crossover comparison of cibenzoline and quinidine in ambulatory patients with chronic ventricular arrhythmias. ( Esterbrooks, DJ; Hansen, JM; Hilleman, DE; Mohiuddin, SM; Mooss, AN; Woodruff, MP, 1989) |
| "This study was designed to compare the efficacy and safety of cibenzoline and quinidine in ambulatory patients with ventricular arrhythmias." | 5.06 | Crossover comparison of cibenzoline and quinidine in ambulatory patients with chronic ventricular arrhythmias. ( Esterbrooks, DJ; Hansen, JM; Hilleman, DE; Mohiuddin, SM; Mooss, AN; Woodruff, MP, 1989) |
| "The efficacy of disopyramide (DP), mexiletine (MX), aprindine (AP) and cibenzoline (CZ) on ventricular arrhythmias was compared (single drug therapy)." | 3.67 | Therapeutic effectiveness and plasma levels of single or combination use of class I antiarrhythmic agents for ventricular arrhythmias. ( Furuya, H; Goto, Y; Tanabe, T; Yoshikawa, H, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawasaki, H | 1 |
| Yahata, K | 1 |
| Okamoto, C | 1 |
| Imamaki, H | 1 |
| Seta, K | 1 |
| Sugawara, A | 1 |
| Brugada, J | 1 |
| Gürsoy, S | 1 |
| Brugada, P | 1 |
| Atié, J | 1 |
| Guiraudon, G | 1 |
| Andries, E | 1 |
| Wijffels, MC | 1 |
| Dorland, R | 1 |
| Allessie, MA | 1 |
| Mohiuddin, SM | 1 |
| Woodruff, MP | 1 |
| Esterbrooks, DJ | 1 |
| Mooss, AN | 1 |
| Hansen, JM | 1 |
| Hilleman, DE | 1 |
| Tanabe, T | 1 |
| Yoshikawa, H | 1 |
| Furuya, H | 1 |
| Goto, Y | 1 |
1 trial available for cifenline and Chronic Disease
| Article | Year |
|---|---|
Crossover comparison of cibenzoline and quinidine in ambulatory patients with chronic ventricular arrhythmias.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chronic Disease; Clinical Trials as Topic | 1989 |
4 other studies available for cifenline and Chronic Disease
| Article | Year |
|---|---|
[Myasthenia-like syndrome induced by cibenzoline overdose in a patient with chronic kidney disease].
Topics: Aged; Anti-Arrhythmia Agents; Chronic Disease; Drug Overdose; Female; Humans; Imidazoles; Kidney Dis | 2008 |
Cibenzoline transforms random re-entry into ordered re-entry in the atria.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Chronic Disease; Depression, Chemical; Ele | 1993 |
Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, and III drugs: a comparison between hydroquinidine, cibenzoline, flecainide, and d-sotalol.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Chronic Disease; Disease Models, Animal; Elect | 1999 |
Therapeutic effectiveness and plasma levels of single or combination use of class I antiarrhythmic agents for ventricular arrhythmias.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Chronic Disease; Disopyramide; | 1988 |